Drug
Galidesivir
Galidesivir: highest development phase Phase 1, developed by BioCryst Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioCryst Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| galidesivir NCT03800173 | Phase 1 | Marburg Virus Disease |
| Galidesivir NCT03891420 | Phase 1 | COVID-19 |
Latest
No recent events.
Follow Galidesivir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.